Nosocomial pneumonia.

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Hospital Epidemiology

Background:

• Nosocomial pneumonia (NP), also known as hospital-acquired pneumonia (HAP), is the second most frequent hospital infection and a leading cause of intensive care unit (ICU) infections.
• NP significantly increases patient morbidity, mortality, healthcare costs, and length of hospital and ICU stays due to increased antibiotic use.

Purpose of the Study:

• To review the pathogenesis, risk factors, prevention strategies, diagnosis, and treatment of nosocomial pneumonia.
• To highlight the importance of timely and appropriate antibiotic management and innovative strategies to combat multi-drug-resistant organisms.

Main Methods:

• Review of existing literature on nosocomial pneumonia, focusing on epidemiology, microbiology, and clinical management.
• Discussion of diagnostic challenges and the role of invasive quantitative cultures.
• Analysis of preventive measures and antibiotic treatment strategies, including empiric and de-escalating approaches.

Main Results:

• Aspiration and upper respiratory tract colonization are primary pathogenic mechanisms for NP.
• Early-onset NP is typically caused by community-acquired pathogens, while late-onset NP involves multi-drug-resistant nosocomial organisms.
• Risk factors include coma, intubation, mechanical ventilation, and supine positioning; prevention involves hand hygiene and avoiding supine position and inappropriate antibiotics.

Conclusions:

• Accurate diagnosis of NP remains challenging, necessitating consideration of invasive diagnostic techniques.
• Prompt, empiric antibiotic treatment based on local resistance patterns, followed by de-escalation, is recommended.
• Innovative strategies like antibiotic rotation may help prevent multi-drug-resistant pathogens and improve survival.